{"id":27976,"date":"2022-05-24T10:31:41","date_gmt":"2022-05-24T08:31:41","guid":{"rendered":"https:\/\/kymos.com\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/"},"modified":"2025-12-03T19:02:24","modified_gmt":"2025-12-03T18:02:24","slug":"pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon","status":"publish","type":"post","link":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/","title":{"rendered":"Pharmaprogress &#8211; Des lueurs d&rsquo;espoir se profilent \u00e0 l&rsquo;horizon"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1170px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\" style=\"--awb-text-transform:none;\"><p><span style=\"font-size: 14pt;\">En 2023, <a href=\"https:\/\/kymos.com\/fr\/pharmaprogress\/\" data-wpel-link=\"internal\">Pharmaprogress<\/a> emm\u00e9nagera dans un b\u00e2timent plus spacieux, plus pratique et \u00e0 la pointe de la technologie dans la r\u00e9gion d&rsquo;Anc\u00f4ne.<\/span> <span style=\"font-size: 14pt;\">Luca Gramaccioni, directeur g\u00e9n\u00e9ral du site Pharmaprogress, et son \u00e9quipe se r\u00e9jouissent de disposer prochainement de plus d&rsquo;espace.<\/span><\/p>\n<blockquote>\n<p><span style=\"font-size: 14pt;\">\u00ab Pharmaprogress a \u00e9t\u00e9 fond\u00e9e en 2001 dans le b\u00e2timent actuel. Vingt ans plus tard, l&rsquo;\u00e9quipe est pass\u00e9e de 6 \u00e0 26 personnes. Nous avons d\u00e9sormais besoin de plus d&rsquo;espace pour r\u00e9pondre \u00e0 la demande croissante pour nos services. \u00bb<\/span><\/p>\n<\/blockquote>\n<\/div><div class=\"fusion-image-element \" style=\"text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><img decoding=\"async\" width=\"400\" height=\"243\" alt=\"Pharmaprogress Ancona\" title=\"New Building V2\" src=\"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2.png\" data-orig-src=\"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2-400x243.png\" class=\"lazyload img-responsive wp-image-27978\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271382%27%20height%3D%27838%27%20viewBox%3D%270%200%201382%20838%27%3E%3Crect%20width%3D%271382%27%20height%3D%27838%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2-200x121.png 200w, https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2-400x243.png 400w, https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2-600x364.png 600w, https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2-800x485.png 800w, https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2-1200x728.png 1200w, https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/New-Building-V2.png 1382w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 850px) 100vw, 1200px\" \/><\/span><\/div><div class=\"fusion-text fusion-text-2\" style=\"--awb-text-transform:none;\"><p><span style=\"font-size: 14pt;\">Cependant, ces nouveaux locaux ne constituent pas le seul investissement r\u00e9cent de Kymos dans sa filiale italienne. L&amp;#39;\u00e9quipe de Pharmaprogress est experte en <strong>extractibles et relargables, en d\u00e9pistage des nitrosamines et en caract\u00e9risation des impuret\u00e9s<\/strong> . Afin d&amp;#39;optimiser la qualit\u00e9 de ces services en termes de sp\u00e9cificit\u00e9 et de sensibilit\u00e9, un spectrom\u00e8tre de masse haute r\u00e9solution (syst\u00e8me Orbitrap) a \u00e9t\u00e9 r\u00e9cemment acquis.  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Luca Gramaccioni explique pourquoi lui et son \u00e9quipe \u00e9taient si impatients de voir l&rsquo;instrument op\u00e9rationnel&nbsp;:<\/span><\/p>\n<blockquote>\n<p><span style=\"font-size: 14pt;\">\u00ab Jusqu&rsquo;\u00e0 pr\u00e9sent, nous avons su r\u00e9pondre aux exigences des projets ambitieux de nos clients gr\u00e2ce \u00e0 notre expertise et \u00e0 notre cr\u00e9ativit\u00e9. D\u00e9sormais, la haute r\u00e9solution, l&rsquo;\u00e9chantillonnage \u00e0 haute fr\u00e9quence et les multiples biblioth\u00e8ques du syst\u00e8me Orbitrap nous facilitent grandement la t\u00e2che et nous permettent d&rsquo;aborder des projets auparavant impossibles. \u00bb <\/span><\/p>\n<\/blockquote>\n<p><span style=\"font-size: 14pt;\">Ce n&rsquo;est pas tout ce qui s&rsquo;est pass\u00e9 r\u00e9cemment chez Pharmaprogress. En 2021, Pharmaprogress a \u00e9tendu ses tests de lots OINPD gr\u00e2ce \u00e0 un nouvel impacteur NGI et des activit\u00e9s de contr\u00f4le qualit\u00e9 de routine \u00e0 grande \u00e9chelle sont actuellement en cours. Parall\u00e8lement, un syst\u00e8me LIMS a \u00e9t\u00e9 mis en place conform\u00e9ment \u00e0 l&rsquo;objectif d&rsquo;un laboratoire sans papier.  <\/span><\/p>\n<blockquote>\n<p><span style=\"font-size: 14pt;\">Le Dr Gramaccioni commente&nbsp;: \u00ab&nbsp;Le syst\u00e8me LIMS repr\u00e9sente un soulagement incroyable pour notre travail quotidien et nous permet de mener \u00e0 bien nos projets encore plus rapidement et plus efficacement. Pour nos clients, l\u2019introduction de la signature num\u00e9rique dans le logiciel Empower est \u00e9galement tr\u00e8s int\u00e9ressante. Gr\u00e2ce \u00e0 cette nouvelle fonctionnalit\u00e9, nous pouvons mettre les donn\u00e9es brutes \u00e0 leur disposition beaucoup plus facilement. Pharmaprogress a toujours eu des exigences de qualit\u00e9 tr\u00e8s \u00e9lev\u00e9es. Mais avec les nouveaux \u00e9quipements, les solutions logicielles et le nouveau b\u00e2timent, nous faisons passer notre laboratoire et notre travail \u00e0 un niveau sup\u00e9rieur.&nbsp;\u00bb<\/span><\/p>\n<\/blockquote>\n<p><span style=\"font-size: 14pt;\">Vous souhaitez en savoir plus sur les innovations et les services existants de Pharmaprogress et du groupe Kymos&nbsp;? Venez rencontrer Luca Gramaccioni et son \u00e9quipe au <strong>61e symposium de l\u2019AFI, du 8 au 10&nbsp;juin \u00e0 Rimini, sur le stand n\u00b0&nbsp;17.<\/strong> Ils seront ravis de vous donner des informations plus d\u00e9taill\u00e9es. Vous pouvez \u00e9galement leur envoyer un courriel.     <\/span><a href=\"mailto:commercial@kymos.com\" data-wpel-link=\"internal\"><span style=\"font-size: 14pt;\">commercial@kymos.com<\/span><\/a> .<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":27979,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[260],"tags":[62],"class_list":["post-27976","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-groupe-kymos","tag-joan"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmaprogress - Site italien de Kymos<\/title>\n<meta name=\"description\" content=\"Pharmaprogress \u00e0 Anc\u00f4ne est le site italien de Kymos. Sp\u00e9cialis\u00e9 dans les substances extractibles et relargables, le d\u00e9pistage des nitrosamines et la caract\u00e9risation des impuret\u00e9s.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaprogress - Site italien de Kymos\" \/>\n<meta property=\"og:description\" content=\"Pharmaprogress \u00e0 Anc\u00f4ne est le site italien de Kymos. Sp\u00e9cialis\u00e9 dans les substances extractibles et relargables, le d\u00e9pistage des nitrosamines et la caract\u00e9risation des impuret\u00e9s.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-24T08:31:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-03T18:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/2022-05-28-PHP-Newsletter_Banner_small.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1458\" \/>\n\t<meta property=\"og:image:height\" content=\"801\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Joan Puig de Dou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joan Puig de Dou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/\"},\"author\":{\"name\":\"Joan Puig de Dou\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"headline\":\"Pharmaprogress &#8211; Des lueurs d&rsquo;espoir se profilent \u00e0 l&rsquo;horizon\",\"datePublished\":\"2022-05-24T08:31:41+00:00\",\"dateModified\":\"2025-12-03T18:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/\"},\"wordCount\":750,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/2022-05-28-PHP-Newsletter_Banner_small.png\",\"keywords\":[\"joan\"],\"articleSection\":[\"Kymos Group\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/\",\"name\":\"Pharmaprogress - Site italien de Kymos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/2022-05-28-PHP-Newsletter_Banner_small.png\",\"datePublished\":\"2022-05-24T08:31:41+00:00\",\"dateModified\":\"2025-12-03T18:02:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"description\":\"Pharmaprogress \u00e0 Anc\u00f4ne est le site italien de Kymos. Sp\u00e9cialis\u00e9 dans les substances extractibles et relargables, le d\u00e9pistage des nitrosamines et la caract\u00e9risation des impuret\u00e9s.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/2022-05-28-PHP-Newsletter_Banner_small.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/2022-05-28-PHP-Newsletter_Banner_small.png\",\"width\":1458,\"height\":801,\"caption\":\"Pharmaprogress - Newsletter\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmaprogress &#8211; Des lueurs d&rsquo;espoir se profilent \u00e0 l&rsquo;horizon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/fr\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\",\"name\":\"Joan Puig de Dou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"caption\":\"Joan Puig de Dou\"},\"description\":\"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.\",\"url\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/author\\\/joan-puig-de-dou\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaprogress - Site italien de Kymos","description":"Pharmaprogress \u00e0 Anc\u00f4ne est le site italien de Kymos. Sp\u00e9cialis\u00e9 dans les substances extractibles et relargables, le d\u00e9pistage des nitrosamines et la caract\u00e9risation des impuret\u00e9s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/","og_locale":"fr_FR","og_type":"article","og_title":"Pharmaprogress - Site italien de Kymos","og_description":"Pharmaprogress \u00e0 Anc\u00f4ne est le site italien de Kymos. Sp\u00e9cialis\u00e9 dans les substances extractibles et relargables, le d\u00e9pistage des nitrosamines et la caract\u00e9risation des impuret\u00e9s.","og_url":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/","og_site_name":"Kymos","article_published_time":"2022-05-24T08:31:41+00:00","article_modified_time":"2025-12-03T18:02:24+00:00","og_image":[{"width":1458,"height":801,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/2022-05-28-PHP-Newsletter_Banner_small.png","type":"image\/png"}],"author":"Joan Puig de Dou","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"\u00c9crit par":"Joan Puig de Dou","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/"},"author":{"name":"Joan Puig de Dou","@id":"https:\/\/kymos.com\/fr\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"headline":"Pharmaprogress &#8211; Des lueurs d&rsquo;espoir se profilent \u00e0 l&rsquo;horizon","datePublished":"2022-05-24T08:31:41+00:00","dateModified":"2025-12-03T18:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/"},"wordCount":750,"image":{"@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/2022-05-28-PHP-Newsletter_Banner_small.png","keywords":["joan"],"articleSection":["Kymos Group"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/","url":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/","name":"Pharmaprogress - Site italien de Kymos","isPartOf":{"@id":"https:\/\/kymos.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/2022-05-28-PHP-Newsletter_Banner_small.png","datePublished":"2022-05-24T08:31:41+00:00","dateModified":"2025-12-03T18:02:24+00:00","author":{"@id":"https:\/\/kymos.com\/fr\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"description":"Pharmaprogress \u00e0 Anc\u00f4ne est le site italien de Kymos. Sp\u00e9cialis\u00e9 dans les substances extractibles et relargables, le d\u00e9pistage des nitrosamines et la caract\u00e9risation des impuret\u00e9s.","breadcrumb":{"@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/2022-05-28-PHP-Newsletter_Banner_small.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2022\/05\/2022-05-28-PHP-Newsletter_Banner_small.png","width":1458,"height":801,"caption":"Pharmaprogress - Newsletter"},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/fr\/news\/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Pharmaprogress &#8211; Des lueurs d&rsquo;espoir se profilent \u00e0 l&rsquo;horizon"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/fr\/#website","url":"https:\/\/kymos.com\/fr\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/kymos.com\/fr\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c","name":"Joan Puig de Dou","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","caption":"Joan Puig de Dou"},"description":"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.","url":"https:\/\/kymos.com\/fr\/news\/author\/joan-puig-de-dou\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/posts\/27976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/comments?post=27976"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/posts\/27976\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/media\/27979"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/media?parent=27976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/categories?post=27976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/tags?post=27976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}